The information provided about medicinal products is intended for informational purposes only and does not constitute an offer, advertisement, or instruction for use. Sale, delivery, and prescription of medications are not carried out through the website. For questions regarding the use of a medication, you can schedule an in-person appointment or online consultation with a relevant specialist at our clinic.
RADACHLORIN
Photosensitizing agent
Dosage form: Concentrate for solution for infusion
Composition:
Active ingredient: Radachlorin – 5.00 g (total sodium salts of chlorin e6, chlorin p6, purpurin 5 – 0.35 g)
Excipients: Meglumine – 0.20 g; Water for injections – up to 100 ml.
Description: A dark green solution with a yellowish tint and a faint characteristic odor.
Indications for use:
· Fluorescent diagnosis of skin cancer.
· Photodynamic therapy of superficial skin tumors (excluding melanoma).
· Photodynamic therapy of pre-tumor (dysplasia grade I-III, erosion) and tumor (cancer in situ) pathology of the cervix.
Contraindications:
· Hypersensitivity to any of the components of the drug.
· Pregnancy and lactation.
· Pediatric use (no clinical experience in children).
Use with caution in individuals with arterial hypertension, diabetes mellitus.
Form of release:
Concentrate for solution for infusion 0.35%.
Composition:
Active ingredient: Radachlorin – 5.00 g (total sodium salts of chlorin e6, chlorin p6, purpurin 5 – 0.35 g)
Excipients: Meglumine – 0.20 g; Water for injections – up to 100 ml.
Description: A dark green solution with a yellowish tint and a faint characteristic odor.
Indications for use:
· Fluorescent diagnosis of skin cancer.
· Photodynamic therapy of superficial skin tumors (excluding melanoma).
· Photodynamic therapy of pre-tumor (dysplasia grade I-III, erosion) and tumor (cancer in situ) pathology of the cervix.
Contraindications:
· Hypersensitivity to any of the components of the drug.
· Pregnancy and lactation.
· Pediatric use (no clinical experience in children).
Use with caution in individuals with arterial hypertension, diabetes mellitus.
Form of release:
Concentrate for solution for infusion 0.35%.
